HIV/AIDS infection in Romania 30 June 2018

Size: px
Start display at page:

Download "HIV/AIDS infection in Romania 30 June 2018"

Transcription

1 HIV/AIDS infection in Romania 30 June 2018

2 The data is collected from the HIV/AIDS confirmation charts, sent by the nine Regional Centers for Evaluation and Monitoring of HIV/AIDS Data and further processed by Compartment for Monitoring and Evaluation of HIV/AIDS data in Romania, in National Institute for Infectious Diseases Prof. Dr. Matei Bals

3 Coordination of counties by the Regional HIV/AIDS Monitoring and Evaluation Centers in Romania INBI PROF.DR. MATEI BALŞ Regional Centre BUCHAREST ARGEŞ BUZĂU DAMBOVIŢA GALAŢI IALOMIŢA ILFOV PRAHOVA VÂLCEA CRAIOVA Regional Centre CONSTANŢA Regional Centre DOLJ GORJ MEHEDINŢI OLT CONSTANŢA TULCEA VRANCEA V. BABEŞ BUCUREŞTI Regional Centre BRĂILA CĂLĂRAŞI GIURGIU TELEORMAN V.BABEŞ- BUCUREŞTI IAŞI Regional Centre BACĂU BOTOŞANI IAŞI NEAMŢ SUCEAVA VASLUI BRAŞOV Regional Centre BRAŞOV COVASNA HARGHITA TÂRGU MUREŞ Regional Centre ALBA BISTRIŢA NĂSĂUD MUREŞ SIBIU BIHOR CLUJ Regional Centre CLUJ MARAMUREŞ SATU MARE SĂLAJ TIMIŞOARA Regional Centre ARAD CARAŞ SEVERIN HUNEDOARA TIMIŞ

4 UNAIDS objectives Source:

5 Ministry of Health, Romania National Institute for Infectious Diseases PROF.DR.MATEI BALŞ Compartment for Monitoring and Evaluation of HIV/AIDS Data in Romania General data at 30 June 2018 TOTAL HIV/AIDS (CUMULATIVE ) OF WHICH: Total AIDS (Cumulative ) Total HIV (Cumulative ) Total no. of AIDS deaths ( ) 739 Out of records HIV/AIDS children + adults NUMBER OF PATIENTS LIVING WITH HIV/AIDS OF WHICH: YEARS YEARS YEARS New HIV/AIDS cases diagnosed in New HIV cases 142 New AIDS cases 115 HIV/AIDS related deaths, confirmed by medical charts in Source: Compartment for Monitoring and Evaluation of HIV/AIDS in Romania - INBI Prof.Dr.M.Balş

6 New HIV/AIDS cases 1 January-30 June 2018

7 Distribution, by counties of new HIV/AIDS cases detected between LEGEND CHILDREN (0-14 YRS) ADULTS AND ADOLESCENTS (> 14 YRS) Source: Compartment for Monitoring and Evaluation of HIV/AIDS in Romania - INBI Prof.Dr.M.Balş

8 Distribution, by gender, of new HIV/AIDS cases detected between (24%) 195 (76%) MALES FEMALES Source: Compartment for Monitoring and Evaluation of HIV/AIDS in Romania - INBI Prof.Dr.M.Balş

9 Distribution, by age and gender, of new HIV/AIDS cases, detected during <1year 1-4 years years years years years years years years >=60 years Males Females Source: Compartment for Monitoring and Evaluation of HIV/AIDS in Romania - INBI Prof.Dr.M.Balş

10 Distribution, by way of transmission, of new HIV/AIDS cases in children and adults, detected between Moter-to-child MSM/Bisexual IDUs* Heterosexual Unknown MALES FEMALES *At we registered 30 HIV/IDU cases - 29 reported as injecting drug use as way of transmission, while 1 reported MSM (men sex with men)/bisexual contact. Source: Compartment for Monitoring and Evaluation of HIV/AIDS in Romania - INBI Prof.Dr.M.Balş

11 CD4 values in new HIV/AIDS cases detected during the first semester of % 8% 27% 35% 11% < > 500 Under assessment Source: Compartment for Monitoring and Evaluation of HIV/AIDS in Romania - INBI Prof.Dr.M.Balş

12 CD4 values in new HIV/AIDS cases in adults, detected during the first semester of 2018 Men Women 23% 10% 17% 7% 27% 27% 37% 30% 12% 10% < > 500 Under assessment < > 500 Under assessment Total cases: 194 Total cases: 60 Source: Compartment for Monitoring and Evaluation of HIV/AIDS in Romania - INBI Prof.Dr.M.Balş

13 Viral load in new HIV/AIDS cases in adults, detected during the first semester of 2018 Men Women 32% 6% 7% 33% 20% 19% 22% 23% 18% 20% < > Under assessment < > Under assessment Source: Compartment for Monitoring and Evaluation of HIV/AIDS in Romania - INBI Prof.Dr.M.Balş

14 New HIV-IDU cases (injecting drug users) 1 January- 30 June 2018

15 New cases of HIV/AIDS (January-June 2018) by injecting drug use Age groups distribution Age group Men Women Total years years years years years years years 1 1 Total Source: Compartment for Monitoring and Evaluation of HIV/AIDS in Romania - INBI Prof.Dr.M.Balş

16 New cases of HIV/AIDS (January-June 2018) by injecting drug use Age groups distribution 31% 3% 3% 13% 10% 23% 17% years years years years years years >=50 years Source: Compartment for Monitoring and Evaluation of HIV/AIDS in Romania - INBI Prof.Dr.M.Balş

17 New cases of HIV/AIDS (January-June 2018) by injecting drug use Counties distribution County Men Women Total Arad 1 1 Bucureşti Călăraşi 2 2 Cluj 1 1 Ilfov 1 1 Mures 1 1 Total Source: Compartment for Monitoring and Evaluation of HIV/AIDS in Romania - INBI Prof.Dr.M.Balş

18 HIV/HBC, HCV, STDs and TB co-infections in IDUs Screened for Number of patients with a positive test % AgHBs 1/ % VHC 17/ % AgHBs + VHC 5/ % STDs (sexually transmitted 3.33% 1/30 diseases) TB co-infection 5/ % Source: Compartment for Monitoring and Evaluation of HIV/AIDS in Romania - INBI Prof.Dr.M.Balş

19 HIV/HBV, HCV, STDs and TB co-infections in IDUs Total patients: % 90.00% 80.00% 70.00% 60.00% 56.66% 50.00% 40.00% 30.00% 20.00% 16.66% 16.66% 10.00% 0.00% 3.33% AgHBs VHC AgHBs + VHC 3.33% STDs TBC Source: Compartment for Monitoring and Evaluation of HIV/AIDS in Romania - INBI Prof.Dr.M.Balş

20 Drugs used by HIV-IDU patients, diagnosed during the first 6 months of % 23% 10% 3% 27% HEROINE HEROINE+NEW HIGHS UNSPECIFIED NEW HIGHS HEROINE+COCAINE+NEW HIGHS Source: Compartment for Monitoring and Evaluation of HIV/AIDS in Romania - INBI Prof.Dr.M.Balş

21 IDUs diagnosed HIV+ during the first 6 months of 2018, who underwent a previous HIV screening Year of previous screening No. patients Total 3 Source: Compartment for Monitoring and Evaluation of HIV/AIDS in Romania - INBI Prof.Dr.M.Balş

22 New HIV/AIDS cases registered in the National HIV/AIDS Data Base during vs. New HIV/AIDS cases in IDUs registered in the National Data Base during CRITERION TOTAL of wich YEAR IDU TOTAL of wich IDU TOTAL of wich IDU TOTAL of wich IDU TOTAL of wich IDU TOTAL of wich IDU TOTAL of wich IDU TOTAL of wich IDU TOTAL of wich IDU TOTAL of wich IDU No. of HIV infections No. of AIDS cases Total number of HIV/AIDS cases Source: Compartment for Monitoring and Evaluation of HIV/AIDS in Romania - INBI Prof.Dr.M.Balş

23 CD4 count in IDUs diagnosed with HIV/AIDS during the first 6 months of % 10% 40% 36% 7% < > 500 Under assessment Source: Compartment for Monitoring and Evaluation of HIV/AIDS in Romania - INBI Prof.Dr.M.Balş

24 Evolution of HIV/AIDS infection in Romania

25 Distribution of ages Age at date of diagnosis/notification Cumulative total Distribution by age of PLWHA Source: Compartment for Monitoring and Evaluation of HIV/AIDS Infection in Romania INBI Prof.Dr.M.Balş

26 Distribution of HIV/AIDS living patients, by age groups, current age and gender at 30 June 2018 (cumulative total ) Age group Male Source: Compartment for Monitoring and Evaluation of HIV/AIDS in Romania - INBI Prof.Dr.M.Balş Gender Female TOTAL < 1 year years years years years years years years years years years years TOTAL

27 Tendencies in routes of transmission in Romania * Route of transmission Vertical** MSM IDU (injecting drug use) MSM/IDU Heterosexual Unkown (1.91%) 19 (4.03%) 6 (1.27%) 1 (0.21%) 367 (77.91%) 69 (14.64%) 13 (2,33%) 43 (7,71%) 4 (0.71%) 424 (76.12%) 73 (13.1%) 23 (4,14%) 51 (9,18%) 11 (1.98%) 1 (0,18%) 419 (75,49%) 50 (9%) 27 (4,7%) 65 (11,32%) 17 (2.96%) 1 (0.17%) 430 (74.91%) 34 (5,92%) 22 (2.81%) 102 (13.04%) 153 (19.56%) 8 (1.02%) 470 (60.1%) 27 (3.45%) 21 (2,3%) 99 (10.86%) 283 (31.06%) 7 (0,76%) 460 (50,49%) 41 (4,5%) 28 (2.89%) 100 (10.34%) 290 (29.98%) 10 (1.03%) 524 (54.18%) 15 (1.55%) 17 (1.87%) 139 (15,35%) 187 (20,66%) 9 (0.99%) 532 (58,78%) 21 (2,32%) 19 (2,27%) 127 (15,19%) 164 (19.61%) 10 (1.19%) 491 (58,73%) 25 (2.99%) 6 (0,78%) 137 (17.97%) 118 (15.48%) 3 (0,39%) 488 (64.04%) 10 (1.31%) 14 (2.02%) 133 (19.21%) 106 (15.31%) 2 (0.28%) 430 (62.13%) 7 (1.01%) 3 (1.2%) 57 (22.2%) 29 (11.3%) 1 (0.4%) 165 (64%) 2 (0.8%) Total *The update of delayed reporting data and the confirmation of cases is performed annually. ** 2017 New bourns perinatally exposed to HIV, whose status was declared HIV infected in 2017 and perinatally exposed to HIV during the previous years and confirmed HIV positive in 2017 Sursa: Compartimentul pentru Monitorizarea şi Evaluarea Infecţiei HIV/SIDA în România INBI Prof.Dr.M.Balş

28 Gender distribution of AIDS cases at 30 June 2018 (Cumulative number ) Males Females Source: Compartment for Monitoring and Evaluation of HIV/AIDS in Romania - INBI Prof.Dr.M.Balş

29 Age groups (at time of diagnosis) and gender distribution of AIDS cases at June (Cumulative total ) < 1 year 1-4 years 5-9 years years years years years years years >=60 years Males Females Source: Compartment for Monitoring and Evaluation of HIV/AIDS in Romania - INBI Prof.Dr.M.Balş

30 Probable route of transmission in children diagnosed with AIDS (0-14 years at time of diagnosis) at 30 June 2018 (cumulative total ) Mother-to-child Blood and derivates* Nosocomial** Heterosexual Unknown Male Female *Persons who received blood transfusions at the end of 1980s and in the early 1990s. **Persons with multiple admissions and/or multiple parenteral treatments at the end of 1980s and in the early 1990s. Source: Compartment for Monitoring and Evaluation of HIV/AIDS in Romania - INBI Prof.Dr.M.Balş

31 Probable route of transmission in teenagers and adults diagnosed with AIDS (>14 at time of diagnosis) at 30 June 2018 (cumulative total ) MSM/Bisexual IDUs Blood and derivates* Heterosexual Unknwon Male Female * Persons who received blood transfusions in the late 1980s and early 1990s Source: Compartment for Monitoring and Evaluation of HIV/AIDS in Romania - INBI Prof.Dr.M.Balş

32 Distribution of AIDS cases in women, by age group and year of diagnosis, between Source: Compartment for Monitoring and Evaluation of HIV/AIDS Infection in Romania INBI Prof.Dr.M.Balş

33 Gender distribution of HIV infection cases at June 30, 2018 (cumulative total ) Male Female Source: Compartment for Monitoring and Evaluation of HIV/AIDS in Romania - INBI Prof.Dr.M.Balş

34 Age group (at time of diagnosis) and gender distribution of HIV infection cases at 30 June 2018 (cumulative total ) < 1 year 1-4 years 5-9 years years years years years years years >=60 years Male Female Source: Compartment for Monitoring and Evaluation of HIV/AIDS in Romania - INBI Prof.Dr.M.Balş

35 Probable route of transmission in children with HIV infection (0-14 years at time of diagnosis) at 30 June 2018 (cumulative total ) Mother-tochild Blood and derivates* Nosocomial** IDUs heterosexual Unknown Male Female *Persons who received blood transfusions at the end of 1980s and in the early 1990s. **Persons with multiple admissions and/or multiple parenteral treatment at the end of 1980s and in the early 1990s. Source: Compartment for Monitoring and Evaluation of HIV/AIDS in Romania - INBI Prof.Dr.M.Balş

36 Probable route of transmission in teenagers and adults with HIV infection (>14 years at time of diagnosis) at 30 June 2018 (cumulative total ) MSM/Bisexual IDUs Blood and derivates* Heterosezual Unknown Male Female * Persons who received blood transfusions at the end of 1980s and in the early 1990s Source: Compartment for Monitoring and Evaluation of HIV/AIDS in Romania - INBI Prof.Dr.M.Balş

37 Distribution of HIV infection in women by years of diagnosis and age group ( ) Source: Compartment for Monitoring and Evaluation of HIV/AIDS Infection in Romania INBI Prof.Dr.M.Balş

38 HBV, HCV and HBV+HCV infection in seropositive children during Source: Compartment for Monitoring and Evaluation of HIV/AIDS Infection in Romania INBI Prof.Dr.M.Balş

39 HBV, HCV and HBV+HCV infection in seropositive adults during Year of diagnosis Source: Compartment for Monitoring and Evaluation of HIV/AIDS Infection in Romania INBI Prof.Dr.M.Balş

40 Associated diseases Tumour-others Pulmonary TB Extrapulmonary TB Toxoplasmosis Wasting Syndrome Recurrent Sepsis Kaposi Sarcoma Recurrent pneumonia Pneumocistis Carinii Penumonia Disseminated mycobacterium Burkitt Lymphoma/others Progressive Multifocal Leucoencephalopathy Bacterial infections, multiple or recurrent HIV Encephaloptahy Cryptosporidiosis Cryptococcosis CMV Disease Pulmonary candidiasis: bronchi/trahea/lungs Candidiasis of the esophagus Invasive cervical cancer Source: Compartment for Monitoring and Evaluation of HIV/AIDS in Romania - INBI Prof.Dr.M.Balş

41 Deaths by year Source: Compartment for Monitoring and Evaluation of HIV/AIDS Infection in Romania INBI Prof.Dr.M.Balş

42 HIV testing January-June 2018

43 HIV testing* in risk groups during the first 6 months of 2018 Risk group Negative tests Positive tests TOTAL %POSITIVE STDs TBC Maternity testing Pregnant women Health workers Pts. with hemodialysis Persons who received transfusions Prenuptial check-up IDUs Prisoners MSM SWs (sex workers) HIV contacts Sailors Drivers Work abroad> 6 months Stay abroad> 6 months On request Occasional TOTAL *The data are sent by the County Public Health Authorities Source: Compartment for Monitoring and Evaluation of HIV/AIDS in Romania - INBI Prof.Dr.M.Balş

44 HIV testing * in pregnant women, by age groups, during the first six months of 2018 Age group Negative tests Positive tests TOTAL %POSITIVE years years years years years years > 40 years Unspecified age TOTAL *The data are sent by the County Public Health Authorities Source: Compartment for Monitoring and Evaluation of HIV/AIDS in Romania - INBI Prof.Dr.M.Balş

45 HIV testing * in blood donors during the first six months of 2018 Group Gender Positive Negative TOTAL %Positive Male ,03 First time donor Regular donor Female ,013 Total ,023 Male ,003 Female ,002 Total ,003 Occasional donor Male ,01 Female Total ,007 TOTAL ,009 *The data are sent by the National Institute for Hematology PROF.C.T.NICOLAU Bucharest

46 CURRENT STANDARDS OF HIV CARE IN ROMANIA

47 Cascade of HIV care - Romania 31 December (93%) (85%) (92%) 7836 (68%) 5500 (37%) 5500 (43%) 5500 (47%) 3968 (51%) E S T I M A T E P L W H A ( U N A I D S 2016) N U M B E R O F P L W H A I N T H E N A T I O N A L D A T A B A S E N U M B E R O F P L W H A F R O M T H E R O M A N I A N C O H O R T P L W A I N A C T I V E R E C O R D S I N T H E N A T I O N A L D A T A B A S E P L W A I N A C T I V E R E C O R D S F R O M T H E R O M A N I A N C O H O R T P L W H A I N A R T I N T H E N A T I O N A L D A T A B A S E P L W H A I N A R T F R O M T H E R O M A N I A N C O H O R T V L < 5 0 C O P I E S / M L I N P A T I E N T S W I T H A R T V L < 5 0 C O P I E S / M L F R O M T H E R O M A N I A N C O H O R T Source: Compartment for Monitoring and Evaluation of HIV/AIDS Data in Romania INBI Prof.Dr.M.Balş / The National HIV/AIDS Data Base Data under assessment

48 Cascade of HIV cares in Romania PLWHA UNAIDS Estimates PLWHA in the national HIV data base Pts. in active records in the national HIV data base Pts. in ART in the national HIV data base from pts. in active records <50 copies/ml from pts. in ART Source: Compartment for Monitoring and Evaluation of HIV/AIDS Data in Romania

49 Source: UNAIDS Estimates for Romania 2017 UNAIDS Estimates for Romania 2017 ROMANIA SELECTED TRENDS AIDS Deaths Number of people living with HIV , AIDS Deaths Lower and upper limits 18,000 16,000 14,000 12,000 10,000 8,000 6,000 Number of people living with HIV Lower and upper limits ,000 2, New HIV Infections Percent of people living with HIV receiving ART 1, New HIV infections Lower and upper limits Percent of people living with HIV receiving ART Lower and upper limits

50 Current standards of care and perspectives related to HIV infection in Romania People living with HIV/AIDS Instruments: National HIV/AIDS Data base (M&E) Young by age but old by treatment Therapeutic fatigue New cases of HIV: young persons, of fertile age, late presentations in the sanitary system Increase in MSM caess Young mothers, with multiple therapeutic schemes Mothers with unknown HIV status- testing recommendation and specific ART treatment for those with confirmed HIV status New approach for perinatally exposed newborn to HIV MTCT Instruments: National Registry of HIV pregnant women and of perinatally exposed newborns Antiretroviral treatment Instruments: National Registry of HIV patients in ART Most ARVs- available in Romania Universal access to treatment Treatment irrespective of CD4 count- since 2001 Suboptimal regimen in the first weeks of life Toxicity associated to ART treatment Psychoactive substances New approach of HIV infected drug using mothers and of perinatally exposed children to HIV and maternal drugs Injecting drug consumers Sursa : M. Mardarescu. Et All. Risk factors involved in late detection of HIV mother to child transmission - data from the National Registry of HIV pregnant women and perinatally exposed children in Romania. 2 nd Vilnius Summit on Communicable Diseases. Oct 4-7, th Congress of the BADV, October 5-7, Vilnius, Lithuania.

51 Current standards of care and perspectives related to HIV infection in Romania Therapeutic fatigue Co-morbidities Aging with HIV Long term therapy+ multiple schemes VF + immunological and virological failure New mechanisms New meanings New attitude New results Drug interactions Risk groups Adjusting the national efforts to the needs of risk/vulnerbale groups Challenges? Sursa: M. Mardarescu. Et All. Risk factors involved in late detection of HIV mother to child transmission - data from the National Registry of HIV pregnant women and perinatally exposed children in Romania. 2 nd Vilnius Summit on Communicable Diseases. Oct 4-7, th Congress of the BADV, October 5-7, Vilnius, Lithuania.

52 HIV/AIDS Phenomenon in the world

53 UNAIDS PARIS DECLARATION 1 December 2014 FAST -- TRACK CITIES: ENDING THE AIDS EPIDEMIC Cities Achieving Targets by % of people living with HIV knowing their HIV status. 90% of people who know their HIV-positive status on treatment. 90% of people on treatment with suppressed viral loads. Source:

54 Global summary of the AIDS epidemic 2017 Number of people living with HIV People newly infected with HIV in 2017 AIDS-related deaths in 2017 Total Adults Women (15+ years) Children (<15 years) Total Adults Children (<15 years) Total Adults Children (<15 years) 36.9 million [31.1 million 43.9 million] 35.1 million [29.6 million 41.7 million] 18.2 million [15.6 million 21.4 million] 1.8 million [1.3 million 2.4 million] 1.8 million [1.4 million 2.4 million] 1.6 million [1.3 million 2.1 million] [ ] [ million] [ million] [ ] Sourse: July Core epidemiology slides

55 million Estimates on the numbers of PLWHA Sourse: July Core epidemiology slides

56 Adults and children estimated to be living with HIV 2017 North America and western and central Europe 2.2 million [1.9 million 2.4 million] Eastern Europe and central Asia 1.4 million [1.3 million 1.6 million] Caribbean [ ] Latin America 1.8 million [1.5 million 2.3 million] Middle East and North Africa [ ] Western and central Africa 6.1 million [4.4 million 8.1 million] Eastern and southern Africa 19.6 million [17.5 million 22.0 million] Asia and the Pacific 5.2 million [4.1 million 6.7 million] Total: 36.9 million [31.1 million 43.9 million] Sourse: July Core epidemiology slides

57 Estimated number of adults and children newly infected with HIV 2017 North America and western and central Europe [ ] Eastern Europe and central Asia [ ] Caribbean [ ] Latin America [ ] Middle East and North Africa [ ] Western and central Africa [ ] Eastern and southern Africa [ million] Asia and the Pacific [ ] Total: 1.8 million [1.4 million 2.4 million] Sourse: July Core epidemiology slides

58 Estimated adult and child deaths from AIDS 2017 North America and western and central Europe [ ] Eastern Europe and central Asia [ ] Caribbean [ ] Latin America [ ] Middle East and North Africa 9800 [ ] Western and central Africa [ ] Eastern and southern Africa [ ] Asia and the Pacific [ ] Total: [ million] Sourse: July Core epidemiology slides

59 Global estimates for children (<15 years) 2017 Children living with HIV 1.8 million [1.3 million 2.4 million] New HIV infections in [ ] AIDS-related deaths in [ ] Sourse: July Core epidemiology slides

60 About 5000 new HIV infections (adults and children) a day 2017 About 66% are in sub-saharian Africa About 500 are among children under 15 years of age About 4400 are among adults aged 15 years and older, of whom: almost 43% are among women about 33% are among young people (15 24) about 19% are among young women (15 24) Sourse: July Core epidemiology slides

61 Regional HIV and AIDS statistics and features 2017 Adults and children living with HIV Adults and children newly infected with HIV Adult and child deaths due to AIDS Eastern and southern Africa 19.6 million [17.5 million 22.0 million] [ million] [ ] Western and central Africa 6.1 million [4.4 million 8.1 million] [ ] [ ] Middle East and North Africa [ ] [ ] 9800 [ ] Asia and the Pacific 5.2 million [4.1 million 6.7 million] [ ] [ ] Latin America 1.8 million [1.5 million 2.3 million] [ ] [ ] Caribbean [ ] [ ] [ ] Eastern Europe and central Asia 1.4 million [1.3 million 1.6 million] [ ] [ ] Western and central Europe and North America 2.2 million [1.9 million 2.4 million] [ ] [ ] TOTAL 36.9 million [31.1 million 43.9 million] 1.8 million [1.4 million 2.4 million] [ million] The ranges around the estimates in this table define the boundaries within which the actual numbers lie, based on the best available information. Sourse: July Core epidemiology slides

62 Characteristics of HIV infection cases diagnosed in the WHO European Region in 2016, by geographical areas WHO European Region West Centre East EU/EEA countrie s Reporting countries/no. of reporting countries* 50/53 (51/53) 23/23 15/15 12/15 (13/15) 31/31 Number of HIV infection cases ( ) ( ) Rate per population 7.7 (18.2) (50.2) 5.9 % of cases: age group 9.4% 10.2% 14.8% 7.1% 10.6% Percentage age 50+ years 15.6% 19.6% 12.1% 12.2% 18.5% Men/women ration Way of transmssion Heterosexual 46.8% 32.9% 27.0% 66.4% 32.3% MSM 23.9% 41.3% 29.9% 3.7% 40.1% I.V. drugs 12.5% 2.9% 2.7% 25.2% 3.6% MTCT 0.7% 0.5% 0.5% 0.9% 0.5% Unknown 16.0% 22.1% 39.7% 3.8% 23.2% * No data received from Russia, Turkmenistan, Uzbekistan. All data presented were reported to ECDC/WHO through the European Surveillance System (TESSy), except for data for Russia which were obtained through the Russian Federal Scientific and Methodological Center for Prevention and Control of AIDS [1]. Russian data are included in the numbers in parentheses for the European Region and the East. ** EU/EEA rate is adjusted for reporting delay (Annex 5), the corresponding estimated number of new diagnoses adjusted for reporting delay is Source: HIV/AIDS Surveillance in Europe 2017;

63 Sursa: UNAIDS WORLD AIDS DAY REPORT 2012 *References UNAIDS, July HIV/AIDS Surveillance in Europe 2016, ECDC

64 References Revised surviellance Case Definition for HIV Infection Among Adults, Adolescents, and Children Aged < 18 Month sand for HIV Infection and AIDS Among Children Aged 18 Months to <13 years--- CDC, United States, CASE DEFINITIONS OF COMMUNICABLE DISEASES :PDF The WHO case definition of HIV surveillance is available at:

65 CASE DEFINITIONS OF COMMUNICABLE DISEASES ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) AND HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION Clinical Criteria (AIDS) Any person who has any of the clinical conditions as defined in the European AIDS case definition for: Adults and adolescents 15 years Children < 15 years of age Laboratory Criteria (HIV) Adults, adolescents and children aged 18 months At least one of the following three: Positive result of a HIV screening antibody test or a combined screening test (HIV antibody and HIV p24 antigen) confirmed by a more specific antibody test (e.g. Western blot) Positive result of 2 EIA antibody test confirmed by a positive result of a further EIA test Positive results on two separate specimens from at least one of the following three: Detection of HIV nucleic acid (HIV-RNA, HIV-DNA) Demonstration of HIV by HIV p24 antigen test, including neutralisation assay Isolation of HIV Children aged < 18 months Positive results on two separate specimens (excluding cord blood) from at least one of the following three: Isolation of HIV Detection of HIV nucleic acid (HIV-RNA, HIV-DNA) Demonstration of HIV by HIV p24 antigen test, including neutralisation assay in a child 1 month of age

66 Epidemiological Criteria NA Case Classification A. Possible case NA B. Probable case NA C. Confirmed case HIV infection Any person meeting the laboratory criteria for HIV infection AIDS Any person meeting the clinical criteria for AIDS and the laboratory criteria for HIV infection

67 National Institute for Infectious Diseases Prof Dr. Matei Bals. Compartment for Monitoring and Evaluation of HIV/AIDS Data in Romania Manager: Prof.Dr. Adrian Streinu-Cercel, MD PhD Head of the Infectious Diseases Department UMF Carol Davila Coordinator: Mariana Mărdărescu MD PhD Coordinator of the Adults programme: Lecturer Dr.Elisabeta Otilia Benea Coordinator of the children s programme: Sorin Petrea MD Statistical data operators: PC operators : As.med. Marieta Iancu Daniela Viţelaru Sanda Vintilă Colaborators Ionel Iosif, MD CNSCBT

The evolution of HIV/AIDS infection in Romania 31 December 2017

The evolution of HIV/AIDS infection in Romania 31 December 2017 The evolution of HIV/AIDS infection in Romania 31 December 2017 The data is collected from the HIV/AIDS confirmation charts, sent by the nine Regional Centers for Evaluation and Monitoring of HIV/AIDS

More information

ROMANIA. HIV/AIDS statistical data 30 June 2013

ROMANIA. HIV/AIDS statistical data 30 June 2013 ROMANIA HIV/AIDS statistical data 30 June 2013 The following information are the synthesis of a collecting process based on HIV/AIDS charts, delivered by nine Regional HIV Centers and Compartment for Monitoring

More information

The evolution of HIV/AIDS Epidemic in Romania 31 December 2013

The evolution of HIV/AIDS Epidemic in Romania 31 December 2013 The evolution of HIV/AIDS Epidemic in Romania 31 December 2013 The data is collected from the HIV/AIDS confirmation charts, sent by the nine Regional Centers for Evaluation and Monitoring of HIV/AIDS Data

More information

Quality of medical services and their impact on the cascade of cares in HIV infection, at national level Roundtable discussion

Quality of medical services and their impact on the cascade of cares in HIV infection, at national level Roundtable discussion Quality of medical services and their impact on the cascade of cares in HIV infection, at national level Roundtable discussion Mariana Mărdărescu MD PhD Adrian Streinu-Cercel MD PhD HC Mike Youle MD PhD

More information

Hepatitis C Burden in Romania Evaluation 2018 Challenges Prof. Adrian Streinu-Cercel MD, PhD, HC

Hepatitis C Burden in Romania Evaluation 2018 Challenges Prof. Adrian Streinu-Cercel MD, PhD, HC Hepatitis C Burden in Romania 2016-2017 Evaluation 2018 Challenges Prof. Adrian Streinu-Cercel MD, PhD, HC Carol Davila University of Medicine and Pharmacy National Institute For Infectious Diseases, Prof.

More information

STRATEGIES FOR MATERNO- FETAL TRANSMISSION OF HIV, HIV AND HBV COINFECTIONS IN CONSTANTA - ROMANIA

STRATEGIES FOR MATERNO- FETAL TRANSMISSION OF HIV, HIV AND HBV COINFECTIONS IN CONSTANTA - ROMANIA STRATEGIES FOR MATERNO- FETAL TRANSMISSION OF HIV, HIV AND HBV COINFECTIONS IN CONSTANTA - ROMANIA Simona Claudia CAMBREA MD, Ph D Faculty of Medicine, Ovidius University, Constanta, Romania Clinical Infectious

More information

HIV and Paediatrics in Central Europe

HIV and Paediatrics in Central Europe 2nd Central and Eastern European Meeting on Viral Hepatitis and Co-Infection with HIV HIV and Paediatrics in Central Europe Mariana Mărdărescu MD PhD Consultant in Infectious Diseases Senior Doctor in

More information

30 years of HIV experience in Romania

30 years of HIV experience in Romania 30 years of HIV experience in Romania UNAIDS objectives Source: http://www.unaids.org/sites/default/files/media_asset/jc2686_wad2014report_en.pdf Europe 2013 Geographical/epidemiological division of the

More information

HIV infection in children. Mariana Mardarescu MD PhD,

HIV infection in children. Mariana Mardarescu MD PhD, HIV infection in children Mariana Mardarescu MD PhD, Paediatric and Adolescents Immunodepression Department National Institute for Infectious Diseases Prof. Dr. Matei Bals, Bucharest A child is not a miniature

More information

Program to control HIV/AIDS

Program to control HIV/AIDS 90-90-90 Program to control HIV/AIDS Hamid Sharifi Associate Professor in Epidemiology [sharifihami@gmail.com] 1 Targets for ending the AIDS epidemic 2 New HIV infections in low- and middle-income countries,

More information

HIV Lecture. Anucha Apisarnthanarak, MD Division of Infectious Diseases Thammasart University Hospital

HIV Lecture. Anucha Apisarnthanarak, MD Division of Infectious Diseases Thammasart University Hospital HIV Lecture Anucha Apisarnthanarak, MD Division of Infectious Diseases Thammasart University Hospital End-2001 global estimates for children and adults People living with HIV/AIDS New HIV infections in

More information

EUROPEAN COMMISSION HEALTH & CONSUMERS DIRECTORATE-GENERAL. Unit G5 - Veterinary Programmes

EUROPEAN COMMISSION HEALTH & CONSUMERS DIRECTORATE-GENERAL. Unit G5 - Veterinary Programmes EUROPEAN COMMISSION HEALTH & CONSUMERS DIRECTORATE-GENERAL Unit G5 - Veterinary Programmes SANCO/10892/2012 Programmes for the eradication, control and monitoring of certain animal diseases and zoonoses

More information

Module 1: HIV epidemiology, transmission and prevention

Module 1: HIV epidemiology, transmission and prevention Session 1 Module goals Module 1 Participants will be able to: -offer an insight into the epidemiological situation in the country and worldwide -present the HIV transmission modes and the broad approaches

More information

QUARTERLY HIV/AIDS SURVEILLANCE REPORT

QUARTERLY HIV/AIDS SURVEILLANCE REPORT QUARTERLY HIV/AIDS SURVEILLANCE REPORT San Francisco Department of Public Health HIV/AIDS Cases Reported Through September 2010 Contents Page Surveillance Summary..... 1 Table 1: Adult/Adolescent HIV/AIDS

More information

Department of Dermatology 2, Colentina Clinical Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania b

Department of Dermatology 2, Colentina Clinical Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania b Mædica - a Journal of Clinical Medicine MAEDICA a Journal of Clinical Medicine 2014; 9(2): 144-150 ORIGINAL PAPERS Epidemiological Aspects of Genital Warts in Romania a 2012 Retrospective Survey Carmen

More information

The programme for the eradication of rabies

The programme for the eradication of rabies EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Director General SANCO/10253/2014 Programmes for the eradication, control and monitoring of certain animal diseases and zoonoses The programme

More information

Key issues for HIV testing and

Key issues for HIV testing and Key issues for HIV testing and counselling in Europe Martin C Donoghoe Programme Manager HIV/AIDS, STI &Viral Hepatitis Programme WHO Europe Key issues for HIV testing & counselling in Europe HIV epidemics

More information

Trends in HIV/AIDS epidemic in Asia, and its challenge. Taro Yamamoto Institute of Tropical Medicine Nagasaki University

Trends in HIV/AIDS epidemic in Asia, and its challenge. Taro Yamamoto Institute of Tropical Medicine Nagasaki University Trends in HIV/AIDS epidemic in Asia, and its challenge Taro Yamamoto Institute of Tropical Medicine Nagasaki University Millennium Development Goals Goal 1. Eradicate extreme poverty and hunger Goal 2.

More information

HOSPITAL MORBIDITY through CERVICAL CANCER - Romania,

HOSPITAL MORBIDITY through CERVICAL CANCER - Romania, Management in healh 4/2009 HOSPITAL MANAGEMENT HOSPITAL MORBIDITY through CERVICAL CANCER - Romania, 2009 - Marius CIUTAN 1, MD Specialist in PHHSM Nona Delia CHIRIAC 1, MD Researcher, senior specialist

More information

Seble G. Kassaye, M.D., M.S. Assistant Professor of Medicine Division of Infectious Diseases and Travel Medicine Georgetown University

Seble G. Kassaye, M.D., M.S. Assistant Professor of Medicine Division of Infectious Diseases and Travel Medicine Georgetown University Seble G. Kassaye, M.D., M.S. Assistant Professor of Medicine Division of Infectious Diseases and Travel Medicine Georgetown University November 5, 2016 None HIV epidemiology Global U.S. Washington, D.C.

More information

Scaling up priority HIV/AIDS interventions in the health sector

Scaling up priority HIV/AIDS interventions in the health sector TOWARDS UNIVERSAL ACCESS? Scaling up priority HIV/AIDS interventions in the health sector Yves Souteyrand, WHO October 2011 Towards universal access targets UN General Assembly High level Meeting June

More information

Romania National Multi-Sectoral HIV/AIDS Commission

Romania National Multi-Sectoral HIV/AIDS Commission UNGASS Indicators Country Report Template Romania National Multi-Sectoral HIV/AIDS Commission Reporting period: January 2003 December 2005 Abbreviations 3 Status at a glance 4 Overview of the AIDS epidemic

More information

GLOBAL HIV STATISTICS

GLOBAL HIV STATISTICS F A C T S H E E T W O R L D A I D S D A Y 2017 GLOBAL HIV STATISTICS 20.9 million people were accessing antiretroviral therapy in June 2017. 36.7 million [30.8 million 42.9 million] people globally were

More information

QUARTERLY AIDS SURVEILLANCE REPORT

QUARTERLY AIDS SURVEILLANCE REPORT QUARTERLY AIDS SURVEILLANCE REPORT San Francisco Department of Public Health AIDS Cases Reported Through June 2010 0 Contents Page Surveillance Summary..... 1 Table 1: Adult/Adolescent AIDS Cases by Transmission

More information

Outline. AIDS & HIV in the Travis County. Global estimates for adults & children end HIV incidence worldwide

Outline. AIDS & HIV in the Travis County. Global estimates for adults & children end HIV incidence worldwide Outline AIDS & HIV in the Joshua Vest Epidemiologist Austin/ Health & Human Services Department Worldwide HIV/AIDS surveillance National Prevalence Trends Disparities Mortality Modes of exposure Risk factors

More information

HIV/AIDS in East Asia

HIV/AIDS in East Asia HIV/AIDS in East Asia Yonsei University Graduate School of Global Health Sohn, Myong Sei Epidemiology Global summary of the AIDS epidemic, 2008 Number of people living with HIV in 2008 Total Adults Women

More information

Can we treat our way out of the HIV epidemic?

Can we treat our way out of the HIV epidemic? Can we treat our way out of the HIV epidemic? Richard E. Chaisson, MD Center for AIDS Research Center for TB Research Johns Hopkins University Schoolboy s (and politician s) tricks for evading the question

More information

AIDS Acquired Immune Deficiency Syndrom

AIDS Acquired Immune Deficiency Syndrom HIV and AIDS World, Europe and Poland Dorota Chrominska-Szosland MD, PhD Nofer Institute of Occupational Medicine Lodz-Poland HIV Human Immunodeficiency Virus AIDS Acquired Immune Deficiency Syndrom 1

More information

ECDC and Spanish Ministry of Health workshop:

ECDC and Spanish Ministry of Health workshop: ECDC and Spanish Ministry of Health workshop: Improving the monitoring of HIV among migrant populations in Europe, Madrid, 3-4 October 2013 Teymur Noori EU Commission Thank Tank on HIV/AIDS Luxembourg,

More information

Towards universal access

Towards universal access Key messages Towards universal access Scaling up priority HIV/AIDS interventions in the health sector September 2009 Progress report Towards universal access provides a comprehensive global update on progress

More information

Epidemiological Characteristics of HIV/AIDS Pandemic in Romania

Epidemiological Characteristics of HIV/AIDS Pandemic in Romania [ Applied Medical Informatics Original Research Vol. 27, No. 4/2010, pp: 31-38 Epidemiological Characteristics of HIV/AIDS Pandemic in Corina-Liana MANIU *, Andrei ACHIMAŞ CADARIU Iuliu Haţieganu University

More information

Progress against the HIV Epidemic: is the end in sight?

Progress against the HIV Epidemic: is the end in sight? Progress against the HIV Epidemic: is the end in sight? Christine Hughes, BscPharm, PharmD, FCSHP Professor, Faculty of Pharmacy & Pharmaceutical Sciences University of Alberta Clinical Pharmacist, Northern

More information

Thresia Sebastian MD, MPH University of Colorado, Denver Global Health Disasters Course October 2016

Thresia Sebastian MD, MPH University of Colorado, Denver Global Health Disasters Course October 2016 Thresia Sebastian MD, MPH University of Colorado, Denver Global Health Disasters Course October 2016 1 Objectives of today s lecture Describe global goals in the fight against HIV Review the epidemiology

More information

ROMANIA. Country Progress Report on AIDS Reporting period January 2014 December 2014

ROMANIA. Country Progress Report on AIDS Reporting period January 2014 December 2014 ROMANIA Country Progress Report on AIDS Reporting period January 2014 December 2014 Bucharest, 2015 1 Contents Abbreviations... 3 I. Status at a glance... 4 a) Inclusiveness of stakeholders in the report-writing

More information

Progress on the targets of Millennium Development Goal 6 in central and eastern Europe and central Asia

Progress on the targets of Millennium Development Goal 6 in central and eastern Europe and central Asia Progress on the targets of Millennium Development Goal 6 in central and eastern Europe and central Asia 11 October 2011 Moscow, Russian Federation Zsuzsanna Jakab WHO Regional Director for Europe Millennium

More information

GLOBAL STATISTICS FACT SHEET 2015

GLOBAL STATISTICS FACT SHEET 2015 FACT SHEET 2015 GLOBAL STATISTICS 15.8 people accessing antiretroviral therapy (June 2015) 36.9 [34.3 41.4 ] people globally were living with HIV (end 2014) 2 [1.9 2.2 ] people became newly infected with

More information

EVALUATION OF THE INFLUENCE OF ECONOMIC, DEMOGRAPHIC AND LEGISLATIVE FACTORS ON THE DEVELOPMENT OF THE NUMBER OF PHARMACIES IN ROMANIA

EVALUATION OF THE INFLUENCE OF ECONOMIC, DEMOGRAPHIC AND LEGISLATIVE FACTORS ON THE DEVELOPMENT OF THE NUMBER OF PHARMACIES IN ROMANIA ORIGINAL ARTICLE EVALUATION OF THE INFLUENCE OF ECONOMIC, DEMOGRAPHIC AND LEGISLATIVE FACTORS ON THE DEVELOPMENT OF THE NUMBER OF PHARMACIES IN ROMANIA MARIUS CĂLIN CHERECHEȘ 1 *, MARA PAULA TIMOFE 2,

More information

Annual Epidemiological Report

Annual Epidemiological Report November 2018 Annual Epidemiological Report 1 HIV in Ireland, 2017 Key Facts There were 492 diagnoses of HIV notified in 2017, a rate of 10.3 per 100,000 population. The HIV rate in Ireland has been relatively

More information

Human Immunodeficiency Virus. Acquired Immune Deficiency Syndrome AIDS

Human Immunodeficiency Virus. Acquired Immune Deficiency Syndrome AIDS Human Immunodeficiency Virus Acquired Immune Deficiency Syndrome AIDS Sudden outbreak in USA of opportunistic infections and cancers in young men in 1981 Pneumocystis carinii pneumonia (PCP), Kaposi s

More information

HIV and PEP. LTC Rose Ressner WRNMMC ID staff Oct 2014 UNCLASSIFIED

HIV and PEP. LTC Rose Ressner WRNMMC ID staff Oct 2014 UNCLASSIFIED HIV and PEP LTC Rose Ressner WRNMMC ID staff Oct 2014 UNCLASSIFIED Disclaimer The views expressed in this presentation are those of the speaker and do not reflect the official policy of the Department

More information

Mortality Rates Among People With HIV, Long on the Wane, Continue to Drop HIV Medicine Feb 2013

Mortality Rates Among People With HIV, Long on the Wane, Continue to Drop HIV Medicine Feb 2013 John F. White III, MD, MBA, FLMI VP and Medical Director American National Insurance Company 1 Mortality Rates Among People With HIV, Long on the Wane, Continue to Drop HIV Medicine Feb 2013 2 1 3 My Opinions

More information

FAST-TRACK COMMITMENTS TO END AIDS BY 2030

FAST-TRACK COMMITMENTS TO END AIDS BY 2030 FAST-TRACK COMMITMENTS TO END AIDS BY 2030 FAST-TRACK COMMITMENTS TO END AIDS BY 2030 90-90-90 1 Ensure that 30 million people living with HIV have access to treatment through meeting the 90 90 90 targets

More information

The outlook for hundreds of thousands adolescents is bleak.

The outlook for hundreds of thousands adolescents is bleak. Adolescents & AIDS Dr. Chewe Luo Chief HIV/AIDS, UNICEF Associate Director, Programmes Division 28/11/17 Professor Father Micheal Kelly Annual Lecture on HIV/AIDS Dublin, Ireland The outlook for hundreds

More information

Colloque scientifique : L économie de la prévention Analysis of Cost-Effectiveness of HIV Prevention

Colloque scientifique : L économie de la prévention Analysis of Cost-Effectiveness of HIV Prevention Colloque scientifique : L économie de la prévention Analysis of Cost-Effectiveness of HIV Prevention Julia Walsh MD, MSc Professor School of Public Health University of California Berkeley Objectives Cost-effectiveness

More information

How has the Polio Eradication Initiative influenced the global AIDS response? Bradley S. Hersh, MD, MPH

How has the Polio Eradication Initiative influenced the global AIDS response? Bradley S. Hersh, MD, MPH How has the Polio Eradication Initiative influenced the global AIDS response? Bradley S. Hersh, MD, MPH Presentation Outline Big history of global HIV epidemic Current status of HIV and the global AIDS

More information

Improving accessibility to antiretroviral drugs: A south-south collaboration

Improving accessibility to antiretroviral drugs: A south-south collaboration Improving accessibility to antiretroviral drugs: A south-south collaboration Jaideep A Gogtay MD Cipla Ltd Mumbai jgogtay@cipla.com Adults and children estimated to be living with HIV at the end of 2000

More information

HIV/AIDS IN EASTERN EUROPE AND CENTRAL ASIA (EECA) Charles Ssonko HIV/TB/Hepatitis Adviser Medecins Sans Frontieres

HIV/AIDS IN EASTERN EUROPE AND CENTRAL ASIA (EECA) Charles Ssonko HIV/TB/Hepatitis Adviser Medecins Sans Frontieres HIV/AIDS IN EASTERN EUROPE AND CENTRAL ASIA (EECA) Charles Ssonko HIV/TB/Hepatitis Adviser Medecins Sans Frontieres Objectives The Epidemiology of HIV/AIDS in the EECA Region (Trends) o The Burden of HIV/AIDS

More information

Mid-term Review of the UNGASS Declaration of. Commitment on HIV/AIDS. Ireland 2006

Mid-term Review of the UNGASS Declaration of. Commitment on HIV/AIDS. Ireland 2006 Mid-term Review of the UNGASS Declaration of Commitment on HIV/AIDS Ireland 2006 Irish Role in Global Response Just as the HIV/AIDS epidemic is a global threat, addressing the challenge of the epidemic

More information

Global health sector strategies on HIV, viral hepatitis and sexually transmitted infections ( )

Global health sector strategies on HIV, viral hepatitis and sexually transmitted infections ( ) Regional Committee for Europe 65th session EUR/RC65/Inf.Doc./3 Vilnius, Lithuania, 14 17 September 2015 2 September 2015 150680 Provisional agenda item 3 ORIGINAL: ENGLISH Global health sector strategies

More information

Media centre. WHO Hepatitis B. Key facts. 1 of :12 AM.

Media centre. WHO Hepatitis B. Key facts.   1 of :12 AM. 1 of 5 2013-08-02 7:12 AM Media centre Hepatitis B Share Print Fact sheet N 204 Updated July 2013 Key facts Hepatitis B is a viral infection that attacks the liver and can cause both acute and chronic

More information

HUMAN IMMUNODEFICIENCY VIRUS (HIV) NON-IMMEDIATE NOTIFICATION STD PROGRAM. Version

HUMAN IMMUNODEFICIENCY VIRUS (HIV) NON-IMMEDIATE NOTIFICATION STD PROGRAM. Version 1 HUMAN IMMUNODEFICIENCY VIRUS (HIV) NON-IMMEDIATE NOTIFICATION STD PROGRAM Event Name: Event Time Period: ADULT HIV 900 (AIDS.gov 12/31/2015) HIV Lifelong HIV (human immunodeficiency virus) is a retrovirus

More information

Concept note. 1. Background and rationale

Concept note. 1. Background and rationale Concept note Inter-Country Workshops for Strengthening Regional and National Human Capacity to Accelerate Scaling up of National PMTCT and Paediatric Care, Support and Treatment Programmes TOWARDS UNIVERSAL

More information

10/17/2015. Chapter 55. Care of the Patient with HIV/AIDS. History of HIV. HIV Modes of Transmission

10/17/2015. Chapter 55. Care of the Patient with HIV/AIDS. History of HIV. HIV Modes of Transmission Chapter 55 Care of the Patient with HIV/AIDS All items and derived items 2015, 2011, 2006 by Mosby, Inc., an imprint of Elsevier Inc. All rights reserved. History of HIV Remains somewhat obscure The earlier

More information

San Francisco AIDS Cases Reported Through December 31, 1998

San Francisco AIDS Cases Reported Through December 31, 1998 San Francisco AIDS Cases Reported Through December 31, 1998 San Francisco Department of Public Health HIV Seroepidemiology and Surveillance Section AIDS Surveillance Unit Contents Page Commentary: Trends

More information

HIV in Myanmar. HIV in Myanmar. Outline. Socio-economic context Epidemiology HIV cascade Testing Treatment Barriers Conclusions 21/02/2017

HIV in Myanmar. HIV in Myanmar. Outline. Socio-economic context Epidemiology HIV cascade Testing Treatment Barriers Conclusions 21/02/2017 ICTMM 21 Sept 2016 Mark Boyd Chair of Medicine/Professorial Fellow University of Adelaide/UNSW University of Adelaide 2 1 University of Adelaide 3 Myanmar BASIC SOCIO-DEMOGRAPHIC INDICATORS Total population

More information

Human Immunodeficiency Virus

Human Immunodeficiency Virus Human Immunodeficiency Virus Isolated in 1983 by Luc Montagnier & Robert Gallo, separately. Genetic material is RNA Carries reverse transcriptase, an enzyme that makes DNA out of RNA in the host cell Cells

More information

Title: Revision of the Surveillance Case Definition for HIV Infection and AIDS Among children age > 18 months but < 13 years

Title: Revision of the Surveillance Case Definition for HIV Infection and AIDS Among children age > 18 months but < 13 years 06-ID-02 Committee: Infectious Disease Title: Revision of the Surveillance Case Definition for HIV Infection and AIDS Among children age > 18 months but < 13 years Statement of problem: Advances in HIV

More information

Transmission and molecular characterisation of wild measles virus in Romania, 2008 to 2012

Transmission and molecular characterisation of wild measles virus in Romania, 2008 to 2012 Research articles Transmission and molecular characterisation of wild measles virus in Romania, 2008 to 2012 G Necula (gnecula@cantacuzino.ro) 1,2, M Lazar 1,2, A Stanescu 3, A Pistol 3, S Santibanez 4,

More information

EDMA HIV-AIDS TEAM Fact Sheet November 2007

EDMA HIV-AIDS TEAM Fact Sheet November 2007 EDMA HIV-AIDS TEAM Fact Sheet November 2007 1. HIV Facts AIDS epidemic update UNAIDS Epidemic Update, November 2007 (1) 760,000 people to be living with HIV in Western and Central Europe in 2007. 31,000

More information

AIDS at 25. Epidemiology and Clinical Management MID 37

AIDS at 25. Epidemiology and Clinical Management MID 37 AIDS at 25 Epidemiology and Clinical Management Blood HIV Transmission transfusion injection drug use Sexual Intercourse heterosexual male to male Perinatal intrapartum breast feeding Regional HIV and

More information

Since the start t of the HIV/ 1980 s: 77.3 million people have be. In million people were liv

Since the start t of the HIV/ 1980 s: 77.3 million people have be. In million people were liv The HIV/AIDS Epidemic and Sustainable Development tgoals Etienne Karita, MD MSc MSPH Kigali, 8 Nov 018 IV/AIDS Burden Since the start t of the HIV/ V/AIDS epidemic i in the early 1980 s: 77.3 million people

More information

On the Fast-Track to end AIDS. HIV & AIDS in the Post 2015 Development Agenda

On the Fast-Track to end AIDS. HIV & AIDS in the Post 2015 Development Agenda On the Fast-Track to end AIDS HIV & AIDS in the Post 2015 Development Agenda Miriam Maluwa Country Director, UNAIDS Ethiopia A i d & d e v e l o p m e n t S u m m i t A d d i s A b a b a 2-3 F e b r u

More information

HIV AND AIDS FACT SHEETS

HIV AND AIDS FACT SHEETS The Human Immunodeficiency Virus (HIV) has been one of the most devastating new diseases to emerge over the course of the past century. Even though HIV may not always be in the headlines now, it is still

More information

Implementing a priority national health care project in Russian Federation (HIV prevention and treatment)

Implementing a priority national health care project in Russian Federation (HIV prevention and treatment) Implementing a priority national health care project in Russian Federation (HIV prevention and treatment) Т.Т.Smolskaya 4-5 October 2006 Expert Group on HIV/AIDS for the NDPHS HIV in Russian Federation

More information

Emerging epidemics: Will they derail progress? Eastern/Central Europe

Emerging epidemics: Will they derail progress? Eastern/Central Europe Emerging epidemics: Will they derail progress? Eastern/Central Europe Marieta Simonova, MD Clinic of Gastroenterology, Military Medical Academy Sofia, Bulgaria Disclosures Speaker/Adviser for AbbVie, Gilead,

More information

HIV/Hepatitis co-infection situation in Romania. Oana Săndulescu, MD, PhD

HIV/Hepatitis co-infection situation in Romania. Oana Săndulescu, MD, PhD HIV/Hepatitis co-infection situation in Oana Săndulescu, MD, PhD Carol Davila University of Medicine and Pharmacy National Institute of Infectious Diseases Prof. Dr. Matei Balș Bucharest, Disclosures Carol

More information

INTEGRATING HIV INTO PRIMARY CARE

INTEGRATING HIV INTO PRIMARY CARE INTEGRATING HIV INTO PRIMARY CARE ADELERO ADEBAJO, MD, MPH, AAHIVS, FACP NO DISCLOSURE 1.2 million people in the United States are living with HIV infection and 1 in 5 are unaware of their infection.

More information

ECDC update to the EU Commission Think Tank on HIV/AIDS

ECDC update to the EU Commission Think Tank on HIV/AIDS ECDC update to the EU Commission Think Tank on HIV/AIDS Andrew Amato Head of HIV, STI and V. Hepatitis programme, ECDC Luxembourg, 10-11 December 2013 Outline Main ECDC reports published since last Think

More information

AIDS at 30 Epidemiology and Clinical Epidemiology and Management MID 37

AIDS at 30 Epidemiology and Clinical Epidemiology and Management MID 37 AIDS at 30 Epidemiology and Clinical Management Blood HIV Transmission transfusion injection drug use Sexual Intercourse heterosexual male to male Perinatal intrapartum breast feeding Adults and children

More information

Prevention and care towards vulnerable and stigmatized populations (MSM, drug users, sex workers)

Prevention and care towards vulnerable and stigmatized populations (MSM, drug users, sex workers) Prevention and care towards vulnerable and stigmatized populations (MSM, drug users, sex workers) Joseph LARMARANGE - CEPED/IRD Symposium ANRS - AIDS 2012-23 July 2012 Epidemiological context» South America

More information

VI.2 Elements for a Public Summary VI.2.1 Overview of Disease Epidemiology

VI.2 Elements for a Public Summary VI.2.1 Overview of Disease Epidemiology VI.2 Elements for a Public Summary VI.2.1 Overview of Disease Epidemiology HIV stands for human immunodeficiency virus. If left untreated, HIV can lead to the disease AIDS (acquired immunodeficiency syndrome).

More information

New Infections (all age groups)

New Infections (all age groups) C H A P T E R 27 Epidemiology BB Rewari The terms /AIDS were unknown just about three and half decades ago, yet it has emerged as one of the leading cause of death among young adults. In July 1981, the

More information

GLOBAL AIDS MONITORING REPORT

GLOBAL AIDS MONITORING REPORT KINGDOM OF SAUDI ARABIA MINISTRY OF HEALTH GLOBAL AIDS MONITORING REPORT COUNTRY PROGRESS REPORT 2017 KINGDOM OF SAUDI ARABIA Submission date: March 29, 2018 1 Overview The Global AIDS Monitoring 2017

More information

HIV-1 Subtypes Circulating in Constanta

HIV-1 Subtypes Circulating in Constanta ARS Medica Tomitana - 2017; 4(23): 163-169 10.1515/arsm-2017-0030 Cernat Roxana-Carmen1, Dumitru Irina Magdalena1, 2, Oțelea D.3, Rugină S. 1,2,4,5 HIV-1 Subtypes Circulating in Constanta 1 Clinical Hospital

More information

New Jersey HIV/AIDS Epidemiologic Profile 2011

New Jersey HIV/AIDS Epidemiologic Profile 2011 New Jersey HIV/AIDS Epidemiologic Profile 2011 HIV/AIDS in New Jersey New Jersey ranks 5th among 46 states with long-term namebased reporting in the rate of HIV (not AIDS) infection among adults and adolescents

More information

Monitoring Recent HIV Infection in Ireland, 2017

Monitoring Recent HIV Infection in Ireland, 2017 Monitoring Recent HIV Infection in Ireland, 2017 January 2019 Key Facts 1 13% of HIV diagnoses in 2017 (of those tested) were likely to be recent infections (within 4 months), using the Recent Infection

More information

Elimination of mother to child transmission of HIV: is the end really in sight? Lisa L. Abuogi, MD University of Colorado, Denver Dec 3, 2014

Elimination of mother to child transmission of HIV: is the end really in sight? Lisa L. Abuogi, MD University of Colorado, Denver Dec 3, 2014 Elimination of mother to child transmission of HIV: is the end really in sight? Lisa L. Abuogi, MD University of Colorado, Denver Dec 3, 2014 Outline Background History of prevention of mother to child

More information

Measure #161: HIV/AIDS: Adolescent and Adult Patients with HIV/AIDS Who Are Prescribed Potent Antiretroviral Therapy

Measure #161: HIV/AIDS: Adolescent and Adult Patients with HIV/AIDS Who Are Prescribed Potent Antiretroviral Therapy Measure #161: HIV/AIDS: Adolescent and Adult Patients with HIV/AIDS Who Are Prescribed Potent Antiretroviral Therapy 2012 PHYSICIAN QUALITY REPTING OPTIONS F INDIVIDUAL MEASURES: REGISTRY ONLY DESCRIPTION:

More information

Overview of the evolution of Highly Pathogenic Avian Influenza H5N8 in poultry and wild birds in Romania

Overview of the evolution of Highly Pathogenic Avian Influenza H5N8 in poultry and wild birds in Romania ROMANIAN GOVERMENT THE NATIONAL SANITARY VETERINARY AND FOOD SAFETY AUTHORITY Overview of the evolution of Highly Pathogenic Avian Influenza H5N8 in poultry and wild birds in Romania PAFF Committee, March

More information

AIDS was described in June 1981 among homosexuals in the USA, and the virus. HIV/AIDS epidemic features and trends in Saudi Arabia

AIDS was described in June 1981 among homosexuals in the USA, and the virus. HIV/AIDS epidemic features and trends in Saudi Arabia ORIGINAL ARTICLE HIV/AIDS epidemic features and trends in Saudi Arabia Yagob Y. Al-Mazrou, PhD, FRCGP; Mohamed H. Al-Jeffri, MSc, DTM&H; Abdulla Ibrahim Fidail, DPH, MPH; Nasir Al-Huzaim, MPH, PhD; Sirrag

More information

When PrEP fails. Laura Waters MD FRCP Mortimer Market Centre London

When PrEP fails. Laura Waters MD FRCP Mortimer Market Centre London When PrEP fails Laura Waters MD FRCP Mortimer Market Centre London www.aidsunited.org PrEP works If people at risk take it If it s taken in the right way If it s available Commissioned/licensed Affordable

More information

HIV Incidence Report, Sexually Transmitted Diseases, HIV and Tuberculosis Section, Epidemiology and Surveillance Unit

HIV Incidence Report, Sexually Transmitted Diseases, HIV and Tuberculosis Section, Epidemiology and Surveillance Unit HIV Incidence Report, 2017 Sexually Transmitted Diseases, HIV and Tuberculosis Section, Epidemiology and Surveillance Unit Introduction (I) These two introduction slides provide a general context for the

More information

HBV/HCV COINFECTIONS IN PATIENTS WITH HIV. Dr Reena Harania MBBS, MRCP, MSc Infectious Disease

HBV/HCV COINFECTIONS IN PATIENTS WITH HIV. Dr Reena Harania MBBS, MRCP, MSc Infectious Disease HBV/HCV COINFECTIONS IN PATIENTS WITH HIV Dr Reena Harania MBBS, MRCP, MSc Infectious Disease Adults and children estimated to be living with HIV as of end 2005 North America 1.2 million [650 000 1.8 million]

More information

Immunodeficiency. (2 of 2)

Immunodeficiency. (2 of 2) Immunodeficiency (2 of 2) Acquired (secondary) immunodeficiencies More common Many causes such as therapy, cancer, sarcoidosis, malnutrition, infection & renal disease The most common of which is therapy-related

More information

HIV infection in pregnancy

HIV infection in pregnancy HIV infection in pregnancy Peter Brocklehurst National Perinatal Epidemiology Unit, University of Oxford What is the size of the problem? in the population as a whole? in women? in pregnant women? in children?

More information

HIV/Hepatitis co-infection situation in BALTIC COUNTRIES

HIV/Hepatitis co-infection situation in BALTIC COUNTRIES 3rd Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV HIV/Hepatitis co-infection situation in BALTIC COUNTRIES Prof. Dr. SAULIUS ČAPLINSKAS Director, Centre for Communicable

More information

Minutes of the 18 th HIV/AIDS Think Tank Meeting 5 and 6 June 2012, Luxembourg

Minutes of the 18 th HIV/AIDS Think Tank Meeting 5 and 6 June 2012, Luxembourg EUROPEAN COMMISSION HEALTH & CONSUMERS DIRECTORATE-GENERAL Directorate C - Public Health and Risk Assessment C4 - Health determinants Minutes of the 18 th HIV/AIDS Think Tank Meeting 5 and 6 June 2012,

More information

Linkage of hepatitis and HIV surveillance systems to improve completeness of injection drug use risk data for co-infected Floridians

Linkage of hepatitis and HIV surveillance systems to improve completeness of injection drug use risk data for co-infected Floridians Linkage of hepatitis and HIV surveillance systems to improve completeness of injection drug use risk data for co-infected Floridians Shana Geary, MPH, CPH United States Conference on AIDS September 7,

More information

HIV-HBV coinfection in HIV population horizontally infected in early childhood between

HIV-HBV coinfection in HIV population horizontally infected in early childhood between UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA FACULTY OF MEDICINE HIV-HBV coinfection in HIV population horizontally infected in early childhood between 1987-1990 Supervising professor: Prof. Cupşa Augustin

More information

In 2013, around 12.9 million people living with HIV had access to antiretroviral therapy.

In 2013, around 12.9 million people living with HIV had access to antiretroviral therapy. F A C T S H E E T 2014 GLOBAL STATISTICS People living with HIV In 2013, there were 35 [33.2 37.2 ] people living with HIV. - Since the start of the epidemic, around 78 [71 87 ] people have become infected

More information

JMSCR Vol 3 Issue 10 Page October 2015

JMSCR Vol 3 Issue 10 Page October 2015 www.jmscr.igmpublication.org Impact Factor 3.79 ISSN (e)-2347-176x DOI: http://dx.doi.org/10.18535/jmscr/v3i10.12 Seroprevalance of Hepatitis B and Hepatitis C Virus Infection among HIV Positive Individuals

More information

Why is there not enough coordination and collaboration between programmes to implement collaboration TB/HIV activities

Why is there not enough coordination and collaboration between programmes to implement collaboration TB/HIV activities Why is there not enough coordination and collaboration between programmes to implement collaboration TB/HIV activities Olga P. Frolova Head of the TB/HIV Health Care Centre, Ministry of Health Social Development,

More information

Screening programmes for Hepatitis B/C in Europe

Screening programmes for Hepatitis B/C in Europe Programme STI, HIV/AIDS and viral hepatitis Screening programmes for Hepatitis B/C in Europe Mika Salminen, Ph.D. European Centre for Disease Prevention and Control Why might screening be needed for hepatitis

More information

The Global State of HIV/AIDS. Presented By: Siobhan K. Young, MPH PhD Candidate at UNC Chapel Hill

The Global State of HIV/AIDS. Presented By: Siobhan K. Young, MPH PhD Candidate at UNC Chapel Hill The Global State of HIV/AIDS Presented By: Siobhan K. Young, MPH PhD Candidate at UNC Chapel Hill siobhany@email.unc.edu Outline HIV/AIDS 101 Origin of AIDS State of the Epidemic HIV/AIDS in Sub-Saharan

More information

HIV EPIDEMIC UPDATE: FACTS & FIGURES 2012

HIV EPIDEMIC UPDATE: FACTS & FIGURES 2012 HIV EPIDEMIC UPDATE: FACTS & FIGURES 2012 Number of Cases Note: In this surveillance report, HIV cases include persons reported with HIV infection (non-aids), advanced HIV (non-aids) and AIDS within a

More information

Tracking the HIV/AIDS epidemic in

Tracking the HIV/AIDS epidemic in 7 th IAS Conference on HIV Pathogenesis, Treatment and Prevention Tracking the HIV/AIDS epidemic in Asia and the Pacific Mr. J.V.R. Prasada Rao UN Secretary General Special Envoy on HIV/AIDS in Asia Pacific

More information

HIV/AIDS MEASURES GROUP OVERVIEW

HIV/AIDS MEASURES GROUP OVERVIEW 2014 PQRS OPTIONS F MEASURES GROUPS: HIV/AIDS MEASURES GROUP OVERVIEW 2014 PQRS MEASURES IN HIV/AIDS MEASURES GROUP: #159. HIV/AIDS: CD4+ Cell Count or CD4+ Percentage Performed #160. HIV/AIDS: Pneumocystis

More information

Integration of recent infection monitoring into national HIV surveillance: 2016 results January 2018

Integration of recent infection monitoring into national HIV surveillance: 2016 results January 2018 Integration of recent infection monitoring into national HIV surveillance: 2016 results January 2018 Key Points In this pilot study, 13% of HIV diagnoses in 2016 were likely to be recent infections (within

More information